Power Sustainable Jun Li on China Market

The video discusses the current COVID-19 situation in Shanghai, highlighting lockdowns in Minhang district and the overall sentiment. It then shifts to market sentiment, noting low risk appetite due to global uncertainties and economic challenges. The discussion covers earnings projections, anticipating a mild recovery despite uncertainties. Investment strategies focus on domestic markets and potential opportunities in Hong Kong. Finally, the impact of US chip sanctions on Chinese manufacturers is analyzed, emphasizing the challenges faced by the industry.

What measures are being taken in Minhang district due to new COVID-19 cases?

• No additional testing required

• Business activities are halted

• Schools are closed for online education only

• Complete lockdown of the district

What factors are contributing to the low market sentiment in Shanghai?

• Global economic uncertainties and the Ukraine war

• Increased consumer spending

• High inflation rates

• Strong real estate market

What is the anticipated earnings growth for the next 12 months?

• 15 to 20%

• 5 to 10%

• 0 to 5%

• 10 to 15%

What is the current investment sentiment towards the Hong Kong market?

• It is considered overpriced

• Investors are highly optimistic

• It is seen as having more downside than upside

• It is considered cheap and possibly oversold

What is a key area of interest for investors in the Asian market?

• Domestic consumption and high yield value stocks

• Foreign real estate

• High-risk tech startups

• Cryptocurrency investments

What impact do US chip sanctions have on Chinese chip makers?

• They have no significant impact

• They increase export opportunities

• They boost production capabilities

• They restrict chip supply and slow down CapEx plans

What is the expected change after the party Congress in terms of policy?

• No changes are expected

• More policy changes or adjustments are anticipated

• Reduction in government intervention

• A complete overhaul of current policies